p53: oncogene or anti-oncogene?

[1]  D. Pim,et al.  The cellular protein p53 in human tumours. , 1984, Molecular biology & medicine.

[2]  T. Soussi,et al.  Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. , 1987, Oncogene.

[3]  D. Lane,et al.  p53 and DNA polymerase α compete for binding to SV40 T antigen , 1987, Nature.

[4]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[5]  H. Koeffler,et al.  Rearrangement of the p53 gene in human osteogenic sarcomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Bernstein,et al.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus , 1985, Nature.

[7]  Wen-Hwa Lee,et al.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity , 1987, Nature.

[8]  J. Yokota,et al.  Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. , 1988, Oncogene.

[9]  H. Koeffler,et al.  Increased expression of p53 protein in human leukemia cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Rilke,et al.  P53 expression in breast cancer , 1988, International journal of cancer.

[11]  C. James,et al.  Mitotic recombination of chromosome 17 in astrocytomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Oren,et al.  Overproduction of p53 antigen makes established cells highly tumorigenic , 1985, Nature.

[13]  Stephen H. Friend,et al.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.

[14]  V. Rotter,et al.  Inhibition of cell growth mediated by plasmids encoding p53 anti-sense. , 1987, Oncogene.

[15]  V. Rotter,et al.  Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Forrest,et al.  ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS , 1988, The Lancet.

[17]  A. Levine,et al.  The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.

[18]  J. Manley,et al.  Repression of simian virus 40 early transcription by viral DNA replication in human 293 cells , 1985, Nature.

[19]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[20]  J. Lebkowski,et al.  Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression , 1985, Nature.

[21]  A. de la Chapelle,et al.  Abnormalities of chromosome No. 17 in myeloproliferative disorders. , 1982, Cancer genetics and cytogenetics.

[22]  M. Cole,et al.  Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes , 1986, Molecular and cellular biology.

[23]  J. Jenkins,et al.  Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells. , 1987, Oncogene.

[24]  M. Oren,et al.  Overproduction of protein p53 contributes to simian virus 40-mediated transformation , 1986, Molecular and cellular biology.

[25]  J. Milner,et al.  The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53. , 1986, Virology.

[26]  A. Levine,et al.  Purification of complexes of nuclear oncogene p53 with rat and Escherichia coli heat shock proteins: in vitro dissociation of hsc70 and dnaK from murine p53 by ATP , 1988, Molecular and cellular biology.

[27]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[28]  A. Bernstein,et al.  Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes , 1987, Journal of virology.

[29]  J. Minna,et al.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.

[30]  J. Jenkins,et al.  Mouse p53 inhibits SV40 origin-dependent DNA replication , 1987, Nature.

[31]  V. Rotter,et al.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene , 1984, Cell.

[32]  L. Kopelovich,et al.  Elevated levels of p53 antigen in cultured skin fibroblasts from patients with hereditary adenocarcinoma of the colon and rectum and its relevance to oncogenic mechanisms. , 1986, Journal of the National Cancer Institute.

[33]  A. Levine,et al.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.

[34]  A. Levine,et al.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation , 1989, Journal of virology.

[35]  S. Benchimol,et al.  Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. , 1988, Oncogene.

[36]  A. Tigges,et al.  Expression of the nuclear oncogene p53 in colon tumours , 1989, The Journal of pathology.

[37]  V. Rotter,et al.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.

[38]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[39]  V. Rotter,et al.  Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species , 1984, Molecular and cellular biology.

[40]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[41]  E. Feinstein,et al.  p 53 in chronic myelogenous leukemia in acute phase ( blast crisis / suppressor genes / allele loss ) , 2022 .

[42]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[43]  E. McCulloch,et al.  Expression of the p53 oncogene in acute myeloblastic leukemia , 1986, The Journal of experimental medicine.

[44]  R. Pollack,et al.  Pre-crisis mouse cells show strain-specific covariation in the amount of 54-kilodalton phosphoprotein and in susceptibility to transformation by simian virus 40. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T. Maimets,et al.  Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity. , 1988, Oncogene.

[46]  I. Herskowitz.  Functional inactivation of genes by dominant negative mutations , 1987, Nature.

[47]  J. Jenkins,et al.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53 , 1984, Nature.

[48]  P. Friedman,et al.  The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen , 1989, Cell.

[49]  A. Bernstein,et al.  Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. , 1988, Oncogene.

[50]  A. Bernstein,et al.  Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation , 1987, Molecular and cellular biology.

[51]  A. Levine,et al.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.

[52]  M. Lübbert,et al.  p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression , 1988, The Journal of experimental medicine.

[53]  A. Levine,et al.  Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.

[54]  J. Jenkins,et al.  The cellular oncogene p53 can be activated by mutagenesis , 1985, Nature.

[55]  P. Gruss,et al.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.

[56]  W. Mercer,et al.  Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies , 1984, Molecular and cellular biology.

[57]  A. Bernstein,et al.  Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia. , 1988, Oncogene.

[58]  J. Jenkins,et al.  Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells , 1988, Molecular and cellular biology.

[59]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[60]  L. Kopelovich.  Skin fibroblasts from humans genetically predisposed to colon cancer are abnormally sensitive to SV40. , 1984, Cancer investigation.

[61]  P. Tegtmeyer,et al.  The p53 complex from monkey cells modulates the biochemical activities of simian virus 40 large T antigen , 1989, Journal of virology.

[62]  S. Benchimol,et al.  Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Yewdell,et al.  Monoclonal antibody analysis of p53 expression in normal and transformed cells , 1986, Journal of virology.